Publications

Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis.

WEERASURIYA, CK; Harris, RC; QUAIFE, M; MCQUAID, CF; WHITE, RG; Gomez, GB;

2021

Vaccines, (2021).9 3 10.3390/vaccines9030245.

Estimating the Force of Infection for Dengue Virus Using Repeated Serosurveys, Ouagadougou, Burkina Faso.

Lim, JK; Carabali, M; EDWARDS, T; Barro, A; Lee, J-S; Dahourou, D; Lee, KS; Nikiema, T; Shin, MY; Bonnet, E; Kagone, T; Kaba, L; Namkung, S; Somé, P-A; Yang, JS; Ridde, V; Yoon, I-K; ALEXANDER, N; Seydou, Y;

2021

Emerging infectious diseases, (2021).27 1 10.3201/eid2701.191650.

Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis.

Calderwood, CJ; Wilson, JP; FIELDING, KL; Harris, RC; Karat, AS; MANSUKHANI, R; FALCONER, J; Bergstrom, M; Johnson, SM; MCCREESH, N; Monk, EJ M; Odayar, J; Scott, PJ; Stokes, SA; Theodorou, H; MOORE, DA J;

2021

PLoS medicine, (2021).18 4 10.1371/journal.pmed.1003566.

The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.

MBURU, CN; OJAL, J; Chebet, R; Akech, D; Karia, B; Tuju, J; Sigilai, A; ABBAS, K; JIT, M; FUNK, S; Smits, G; Van Gageldonk, PG M; Van der Klis, FR M; Tabu, C; Nokes, DJ; LSHTM CMMID COVID-19 Working Group,; SCOTT, J; FLASCHE, S; ADETIFA, I;

2021

BMC medicine, (2021).19 1 10.1186/s12916-021-01906-9.

UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records.

Walker, JL; GRINT, DJ; STRONGMAN, H; EGGO, RM; Peppa, M; MINASSIAN, C; MANSFIELD, KE; RENTSCH, CT; DOUGLAS, IJ; MATHUR, R; WONG, AY S; Quint, JK; Andrews, N; Bernal, JL; SCOTT, JA; Ramsay, M; SMEETH, L; MCDONALD, HI;

2021

BMC public health, (2021).21 1 10.1186/s12889-021-10427-2.

Prospective association of social circumstance, socioeconomic, lifestyle and mental health factors with subsequent hospitalisation over 6–7 year follow up in people living with HIV.

Rein, SM; Smith, CJ; Chaloner, C; Stafford, A; Rodger, AJ; Johnson, MA; McDonnell, J; Burns, F; Madge, S; MINERS, A; Sherr, L; Collins, S; Speakman, A; Phillips, AN; Lampe, FC;

2021

EClinicalMedicine, (2021).31, 10.1016/j.eclinm.2020.100665.

Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria.

Watson, OJ; ALHAFFAR, M; Mehchy, Z; Whittaker, C; Akil, Z; Brazeau, NF; Cuomo-Dannenburg, G; Hamlet, A; Thompson, HA; Baguelin, M; FitzJohn, RG; Knock, E; Lees, JA; Whittles, LK; Mellan, T; Winskill, P; Imperial College COVID-19 Response Team,; HOWARD, N; Clapham, H; CHECCHI, F; Ferguson, N; Ghani, A; Beals, E; Walker, P;

2021

Nature communications, (2021).12 1 10.1038/s41467-021-22474-9.

Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, India.

DIAL, NJ; MEDLEY, GF; CROFT, SL; Mahapatra, T; Priyamvada, K; Sinha, B; Palmer, L; TERRIS-PRESTHOLT, F;

2021

PLoS neglected tropical diseases, (2021).15 2 10.1371/journal.pntd.0009129.

The Governance and Implementation of the National Action Plan on Antimicrobial Resistance in Tanzania: A Qualitative Study.

Frumence, G; Mboera, LE G; Sindato, C; Katale, BZ; Kimera, S; Metta, E; DURRANCE-BAGALE, A; JUNG, A-S; Mshana, SE; CLARK, TG; Rweyemamu, M; LEGIDO-QUIGLEY, H; Matee, MI N;

2021

Antibiotics, (2021).10 3 10.3390/antibiotics10030273.

COVID-19 vaccine challenges: What have we learned so far and what remains to be done?.

Forman, R; Shah, S; Jeurissen, P; JIT, M; Mossialos, E;

2021

Health policy (Amsterdam, Netherlands), (2021).125 5 10.1016/j.healthpol.2021.03.013.